NEXT GENERATION TOOLS FOR GENOME-CENTRIC MULTIMODAL DATA INTEGRATION IN PERSONALISED CARDIOVASCULAR MEDICINE
Acronym
NextGen
Description of the granted funding
Healthcare is the fasted growing EU27 expenditure. Personalised medicine, comprising tailored approaches for prevention, diagnosis, monitoring and treatment is essential to reduce the burden of disease and improve the quality of life. Integration of multiple data types (multimodal data) into artificial intelligence models is required for the development of accurate and personalised interventions. This is particularly true for the inclusion of genomic data, which is information-rich and individual-specific, and more routinely available as the cost of sequencing continues to fall. Multimodal data integration is complex due to privacy & governance requirements, the presence of multiple standards, distinct data formats, and underlying data complexity and volume. NextGen tools will remove barriers in data integration several cardiovascular use cases. NextGen deliverables will include tooling for multimodal data integration and research portability, extension of secure federated analytics to genomic computation, more effective federated learning over distributed infrastructures, more effective and accessible tools for genomic data analysis; improved clinical efficiency of variant prioritisation; scalable genomic data curation; and improved data discoverability and data management. A comprehensive gap analysis of the existing landscape, factoring ongoing initiatives will ensure NextGen deliverables are forward-looking and complementary. NextGen embedded governance framework and robust regulatory processes will ensure secure multi-jurisdictional multiomic multimodal data access aligned with initiatives including “1+ Million Genomes” and the European Health Data Space. Several real-world pilots will demonstrate the effectiveness of NextGen tools and will be integrated in the NextGen Pathfinder network of five collaborating clinical sites as a self-contained data ecosystem and comprehensive proof of concept.
Show moreStarting year
2024
End year
2027
Granted funding
MYDATA GLOBAL RY
104 375 €
Participant
LIKE HEALTHCARE RESEARCH GMBH (DE)
100 000 €
Participant
WELLSPAN HEALTH (US)
500 000 €
Participant
DPO Associates Sarl (CH)
Participant
Drug Information Association Inc. (DIA), Branch Basel (CH)
Participant
DATAPOWER SRL (IT)
225 000 €
Participant
The Human Colossus Foundation (CH)
Participant
NEBS (BE)
208 750 €
Participant
HIRO MICRODATACENTERS B.V. (NL)
1 497 500 €
Participant
HL7 INTERNATIONAL FONDATION (BE)
104 000 €
Participant
EARLHAM INSTITUTE (UK)
Participant
UNIVERSITY OF VIRGINIA (US)
486 172.5 €
Participant
SOCIETE EUROPEENNE DE CARDIOLOGIE (FR)
255 087.5 €
Participant
SCUOLA UNIVERSITARIA PROFESSIONALE DELLA SVIZZERA ITALIANA (CH)
Participant
EURECOM (FR)
612 762.5 €
Participant
QUEEN MARY UNIVERSITY OF LONDON (UK)
Participant
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN (DE)
97 180 €
Participant
UNIVERSITAIR MEDISCH CENTRUM UTRECHT (NL)
2 300 000 €
Coordinator
KAROLINSKA INSTITUTET (SE)
504 000 €
Participant
JOHANN WOLFGANG GOETHE-UNIVERSITATFRANKFURT AM MAIN (DE)
507 295 €
Participant
Amount granted
7 601 770 €
Funder
European Union
Funding instrument
HORIZON Research and Innovation Actions
Framework programme
Horizon Europe (HORIZON)
Call
Programme part
Health (11673 Tools, Technologies and Digital Solutions for Health and Care, including personalised medicine (11693 )
Topic
Better integration and use of health-related real-world and research data, including genomics, for improved clinical outcomes (HORIZON-HLTH-2023-TOOL-05-04Call ID
HORIZON-HLTH-2023-TOOL-05 Other information
Funding decision number
101136962